The Plasma Membrane Monoamine Transporter is Highly Expressed in Neuroblastoma and Functions as an mIBG Transporter.


Journal

The Journal of pharmacology and experimental therapeutics
ISSN: 1521-0103
Titre abrégé: J Pharmacol Exp Ther
Pays: United States
ID NLM: 0376362

Informations de publication

Date de publication:
12 2023
Historique:
received: 30 03 2023
accepted: 06 07 2023
pmc-release: 01 12 2024
medline: 17 11 2023
pubmed: 5 8 2023
entrez: 4 8 2023
Statut: ppublish

Résumé

Neuroblastoma (NB) is a pediatric cancer with low survival rates in high-risk patients.

Identifiants

pubmed: 37541765
pii: jpet.123.001672
doi: 10.1124/jpet.123.001672
pmc: PMC10658915
doi:

Substances chimiques

3-Iodobenzylguanidine 35MRW7B4AD
Iodine-131 0
N-Myc Proto-Oncogene Protein 0
Membrane Transport Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

239-248

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM066233
Pays : United States

Informations de copyright

Copyright © 2023 by The American Society for Pharmacology and Experimental Therapeutics.

Références

Endocrine. 2016 May;52(2):214-21
pubmed: 26690657
Cold Spring Harb Perspect Med. 2013 Oct 01;3(10):a014415
pubmed: 24086065
Biochim Biophys Acta. 2014 Aug;1846(1):13-25
pubmed: 24709009
J Clin Endocrinol Metab. 2003 Apr;88(4):1880-8
pubmed: 12679487
J Biol Chem. 2013 Feb 1;288(5):3535-44
pubmed: 23255610
Biochem Pharmacol. 1990 Jun 15;39(12):1959-64
pubmed: 2353937
Eur J Cancer. 2014 Mar;50(4):801-15
pubmed: 24333097
Cells. 2022 Aug 08;11(15):
pubmed: 35954298
Oncotarget. 2016 Jun 14;7(24):36293-36310
pubmed: 27167114
Children (Basel). 2018 Aug 28;5(9):
pubmed: 30154341
Int J Mol Imaging. 2012;2012:250834
pubmed: 23050139
Biochem J. 2016 Apr 1;473(7):929-36
pubmed: 26831515
Onco Targets Ther. 2019 May 17;12:3881-3891
pubmed: 31190887
Hematol Oncol Clin North Am. 2010 Feb;24(1):65-86
pubmed: 20113896
Pediatr Hematol Oncol. 2017 Apr;34(3):165-185
pubmed: 28662353
Cell Tissue Res. 2018 May;372(2):195-209
pubmed: 29572647
Theranostics. 2021 Apr 15;11(13):6251-6277
pubmed: 33995657
Int J Cancer. 1991 Apr 1;47(6):875-80
pubmed: 2010230
Neuroscience. 2007 May 25;146(3):1193-211
pubmed: 17408864
Drug Metab Dispos. 2022 Feb 22;:
pubmed: 35197314
Cancer Res. 1993 Jan 15;53(2):304-9
pubmed: 8417824
Pediatr Clin North Am. 2015 Feb;62(1):225-56
pubmed: 25435121
Br J Cancer. 1991 Aug;64(2):293-5
pubmed: 1892758
Cancer Res. 1991 Aug 15;51(16):4342-6
pubmed: 1868458
Cancer Lett. 2016 Sep 28;380(1):304-14
pubmed: 26597947
Pediatr Blood Cancer. 2015 Jan;62(1):5-11
pubmed: 25175627
Exp Oncol. 2015 Jun;37(2):111-5
pubmed: 26112937
Front Oncol. 2012 Jan 06;1:58
pubmed: 22655253
Endocr Rev. 2003 Feb;24(1):48-77
pubmed: 12588808
J Biol Chem. 2004 Nov 26;279(48):50042-9
pubmed: 15448143
Clin Pharmacol Ther. 2016 Nov;100(5):489-499
pubmed: 27506881
Drug Metab Dispos. 2015 Nov;43(11):1773-80
pubmed: 26285765
Semin Nucl Med. 2016 May;46(3):184-202
pubmed: 27067500
Int J Cancer. 1991 Jan 2;47(1):105-9
pubmed: 1985865
BMC Cancer. 2014 Apr 30;14:303
pubmed: 24884806
Mol Pharmacol. 2022 May;101(5):334-342
pubmed: 35193935
Mol Pharmacol. 2020 Aug;98(2):109-119
pubmed: 32487736
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1931-6
pubmed: 12574499
Front Oncol. 2012 Dec 17;2:194
pubmed: 23251904
J Pharmacol Exp Ther. 2010 Dec;335(3):743-53
pubmed: 20858707
J Nucl Med. 2015 Jun;56(6):839-46
pubmed: 25883126
Pediatr Blood Cancer. 2016 Feb;63(2):221-7
pubmed: 26469522
Front Oncol. 2021 Jan 27;10:624079
pubmed: 33585251
Handb Exp Pharmacol. 2021;266:253-280
pubmed: 33751232
Int J Cancer. 1990 Aug 15;46(2):276-81
pubmed: 2384275
J Cell Sci. 2009 Sep 15;122(Pt 18):3393-402
pubmed: 19706688
Eur J Cancer. 1995;31A(4):582-6
pubmed: 7576973
Pediatr Transplant. 2020 Mar;24(2):e13658
pubmed: 31960542
Pediatr Blood Cancer. 2013 Jun;60(6):985-93
pubmed: 23255319
Drug Metab Dispos. 2012 Jun;40(6):1138-43
pubmed: 22396231
Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):474-481
pubmed: 26338179

Auteurs

Letícia Salvador Vieira (LS)

Department of Pharmaceutics, University of Washington, Seattle, Washington (L.S.V., Y.Z., A.J.L.Q., T.H., J.W.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (D.K.S., B.P.); and Seattle Children's Hospital, Seattle, Washington (J.S., J.R.P.).

Yuchen Zhang (Y)

Department of Pharmaceutics, University of Washington, Seattle, Washington (L.S.V., Y.Z., A.J.L.Q., T.H., J.W.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (D.K.S., B.P.); and Seattle Children's Hospital, Seattle, Washington (J.S., J.R.P.).

Antonio J López Quiñones (AJ)

Department of Pharmaceutics, University of Washington, Seattle, Washington (L.S.V., Y.Z., A.J.L.Q., T.H., J.W.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (D.K.S., B.P.); and Seattle Children's Hospital, Seattle, Washington (J.S., J.R.P.).

Tao Hu (T)

Department of Pharmaceutics, University of Washington, Seattle, Washington (L.S.V., Y.Z., A.J.L.Q., T.H., J.W.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (D.K.S., B.P.); and Seattle Children's Hospital, Seattle, Washington (J.S., J.R.P.).

Dilip Kumar Singh (DK)

Department of Pharmaceutics, University of Washington, Seattle, Washington (L.S.V., Y.Z., A.J.L.Q., T.H., J.W.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (D.K.S., B.P.); and Seattle Children's Hospital, Seattle, Washington (J.S., J.R.P.).

Jeffrey Stevens (J)

Department of Pharmaceutics, University of Washington, Seattle, Washington (L.S.V., Y.Z., A.J.L.Q., T.H., J.W.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (D.K.S., B.P.); and Seattle Children's Hospital, Seattle, Washington (J.S., J.R.P.).

Bhagwat Prasad (B)

Department of Pharmaceutics, University of Washington, Seattle, Washington (L.S.V., Y.Z., A.J.L.Q., T.H., J.W.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (D.K.S., B.P.); and Seattle Children's Hospital, Seattle, Washington (J.S., J.R.P.).

Julie R Park (JR)

Department of Pharmaceutics, University of Washington, Seattle, Washington (L.S.V., Y.Z., A.J.L.Q., T.H., J.W.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (D.K.S., B.P.); and Seattle Children's Hospital, Seattle, Washington (J.S., J.R.P.).

Joanne Wang (J)

Department of Pharmaceutics, University of Washington, Seattle, Washington (L.S.V., Y.Z., A.J.L.Q., T.H., J.W.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (D.K.S., B.P.); and Seattle Children's Hospital, Seattle, Washington (J.S., J.R.P.) jowang@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH